Trial Profile
A Rand. Trial Comp Higher Doses of Rituximab (Rituxan) With Standard Doses of Rituxan in Combination With CVP (Cyclophosphamide, Vincristine, and Prednisone) in Patients With Chronic ITP Who Have Failed/Relapsed After Rituxan Treatment
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 11 Jan 2019
Price :
$35
*
At a glance
- Drugs Rituximab (Primary) ; Cyclophosphamide; Prednisone; Vincristine
- Indications Idiopathic thrombocytopenic purpura
- Focus Therapeutic Use
- 24 Oct 2014 New trial record